Alliance For Cancer Gene Therapy Inc
- Assets
- $7.9m
- Revenue
- $3.2m
- Investments
- $0.0
- Employees
- 2
- Location
- Stamford, CT
- Founding
- 07/2001
- Data as of
- 04/2023
- EIN
- 06-1619523
Organization Overview
Alliance For Cancer Gene Therapy Inc is located in Stamford, CT. The organization was established in 2001. According to its NTEE Classification (T30) the organization is classified as: Public Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 04/2023, Alliance For Cancer Gene Therapy Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alliance For Cancer Gene Therapy Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 04/2023, Alliance For Cancer Gene Therapy Inc generated $3.2m in total revenue. This organization has experienced exceptional growth, as over the past 3 years, it has increased revenue by an average of 23.5% each year . All expenses for the organization totaled $2.5m during the year ending 04/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2021, Alliance For Cancer Gene Therapy Inc has awarded 20 individual grants totaling $4,732,224. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ALLIANCE FOR CANCER GENE THERAPY FUNDS INNOVATIVE SCIENTISTS WORKING TO(CONTINUED ON SCHEDULE O)(CONTINUED)HARNESS THE POWER OF CELL AND GENE THERAPY TO TRANSFORM HOW CANCER IS TREATED AND DRIVE MOMENTUM TOWARDS A CURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN FISCAL 04/30/23, ACGT FUNDED CLINICAL INVESTIGATOR GRANTS (AWARDED TO INNOVATIVE SCIENTISTS CONDUCTING TRANSLATIONAL RESEARCH) AT PREMIER ACADEMIC INSTITUTIONS IN THE U.S,, EACH FOCUSING ON THE DEVELOPMENT OF CANCER CELL AND GENE THERAPIES FOR DIFFERENT CANCERS INCLUDING LUNG, PANCREATIC, PROSTATE, OVARIAN AND BRAIN CANCERS, PEDIATRIC SARCOMAS AND CANCER METASTASIS. IN ADDITION, ACGT CONTINUED MULTI-YEAR COLLABORATIONS WITH OTHER MULTI-DISCIPLINARY 501(C)(3) ORGANIZATIONS FOCUSED ON CELL AND GENE THERAPY RESEARCH. ACGT FURTHER INCREASED PUBLIC AWARENESS OF CELL AND GENE THERAPY RESEARCH THROUGH SCIENTIFIC SEMINARS, ACGT'S WEBSITE, SOCIAL MEDIA AND AVAILABLE MARKETING MATERIALS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Barbara Netter Honorary Chairman | Trustee | 6 | $0 |
Kevin Honeycutt President, CEO & Director | OfficerTrustee | 40 | $0 |
Gbola Amusamd Director | Trustee | 1 | $0 |
Teresa Burgess PHD Director | Trustee | 1 | $0 |
Daniel Englander Director | Trustee | 1 | $0 |
Maria Fardis PHD Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Mintz Levin Cohn Ferris Glovsky And Legal | 4/29/21 | $198,610 |
Mito Pop Brand Consultant | 4/29/21 | $114,614 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $16,983 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,185,203 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,202,186 |
| Total Program Service Revenue | $196,753 |
| Investment income | $134,870 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $395,629 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $300,263 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $3,231,770 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,735,344 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $267,581 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $124,123 |
| Pension plan accruals and contributions | $3,673 |
| Other employee benefits | $10,315 |
| Payroll taxes | $10,991 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $41,648 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $45,988 |
| Advertising and promotion | $27,028 |
| Office expenses | $18,195 |
| Information technology | $74,258 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $33,574 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $75,855 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $30,006 |
| Total functional expenses | $2,498,579 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $682,694 |
| Savings and temporary cash investments | $1,852,321 |
| Pledges and grants receivable | $16,000 |
| Accounts receivable, net | $50 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $40,461 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $5,337,857 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $7,929,383 |
| Accounts payable and accrued expenses | $23,143 |
| Grants payable | $1,650,923 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,674,066 |
| Net assets without donor restrictions | $4,020,483 |
| Net assets with donor restrictions | $2,234,834 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $7,929,383 |
Grants Awarded
Over the last fiscal year, Alliance For Cancer Gene Therapy Inc has awarded $1,735,341 in support to 6 organizations.
| Grant Recipient | Amount |
|---|---|
BROWNICAHN SCHOOL PURPOSE: CANCER RESEARCH | $213 |
CHEN YALE UNIV PURPOSE: CANCER RESEARCH | $143 |
OKADA UNIV OF CA PURPOSE: CANCER RESEARCH | $492,904 |
FUEYO UNIV OF TEXAS PURPOSE: CANCER RESEARCH | $480,024 |
PCI PURPOSE: CANCER RESEARCH | $750,000 |
ZUREIKAT UNIV PITTS PURPOSE: CANCER RESEARCH | $12,057 |